Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TVTX
TVTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TVTX News
Travere Therapeutics Secures FDA Approval for Filspari
21h ago
Yahoo Finance
US Stocks Surge as Oil Prices Plunge Amid Ceasefire Talks
5d ago
NASDAQ.COM
Travere Therapeutics Grants Equity Inducements to New Employees
6d ago
Newsfilter
US Stocks Rally as Oil Prices Plunge
6d ago
NASDAQ.COM
US Stocks Rise on Hopes of Iran Ceasefire Negotiations
6d ago
NASDAQ.COM
FDA Approves Filspari for Rare Kidney Disorder Treatment
6d ago
stocktwits
FDA Approves Travere and Ligand's Joint Kidney Disease Therapy Expansion
6d ago
seekingalpha
FILSPARI Receives FDA Approval for FSGS Treatment
6d ago
Newsfilter
Travere Therapeutics Receives FDA Approval for FILSPARI to Treat FSGS
6d ago
NASDAQ.COM
Travere Therapeutics Receives FDA Approval for New Drug
6d ago
stocktwits
FDA Approves FILSPARI for FSGS Treatment
6d ago
Newsfilter
FDA Extends Review Period for Filspari Drug Application
Apr 10 2026
stocktwits
FDA Accelerates Biosimilar Drug Development and Approves New Treatments
Mar 30 2026
NASDAQ.COM
Travere Therapeutics Q4 2025 Earnings Call Highlights
Feb 20 2026
seekingalpha
Travere Therapeutics Reports Q4 Profit Exceeding Expectations
Feb 19 2026
Yahoo Finance
Travere Therapeutics Q4 Earnings Analysis
Feb 19 2026
seekingalpha
Show More News
